GLP-1 Compounding Exclusion
A GLP-1 compounding exclusion is a policy provision that removes or restricts coverage for defined claims involving compounded glucagon-like peptide-1 medications.
Definition
A GLP-1 compounding exclusion is language within an insurance policy that excludes or limits coverage for liability, injury, loss, defense costs, or other specified exposures arising from compounded glucagon-like peptide-1 medications. The exclusion may apply to activities involving the prescribing, ordering, preparation, sourcing, dispensing, distribution, administration, storage, representation, or monitoring of a compounded GLP-1 medication.
The term describes a coverage boundary rather than a standardized exclusion form. Its legal and operational scope is determined by the wording contained in the applicable policy, endorsement, application, or incorporated coverage document.
Structural Components
- Excluded subject matter: Identifies compounded GLP-1 medications, designated active ingredients, compounded weight-management drugs, or a broader category of non-approved compounded pharmaceuticals.
- Excluded activities: Specifies whether the restriction applies to prescribing, compounding, dispensing, administering, selling, distributing, recommending, or supervising the medication.
- Causation language: Establishes the connection required between the excluded activity and a claim through phrases addressing claims arising out of, resulting from, based upon, or related to the activity.
- Affected coverage: Identifies the policy section to which the exclusion applies, which may include professional liability, general liability, product liability, or another coverage component.
- Exceptions or carve-backs: States whether limited coverage is restored when defined conditions, sources, approvals, or professional protocols are present.
- Endorsement controls: Determines whether the exclusion modifies, replaces, or supersedes language in the underlying policy form.
Parameters & Conditions
The exclusion may be written as a complete prohibition or as a conditional restriction. A complete exclusion removes coverage for the defined category of GLP-1 compounding exposure regardless of the individual facts of a claim. A conditional exclusion applies only when specified requirements are not satisfied.
Relevant parameters may include the identity or licensing status of the compounding facility, the source of the active pharmaceutical ingredient, the medication formulation, the reason for compounding, the professional services performed by the insured, and the relationship between those services and the alleged injury.
Application also depends on the policy period, retroactive date, applicable insuring agreement, definition of professional services, and any other exclusion that independently affects the claim.
Topic Relationships
Exceptions, Limitations & Boundaries
A GLP-1 compounding exclusion does not necessarily exclude every claim involving a GLP-1 medication. Language limited to compounded medications may not apply to the same active ingredient when supplied in a form outside the exclusion’s definition.
The exclusion also does not independently determine whether a medication may lawfully be compounded, prescribed, dispensed, or administered. Regulatory permissibility and insurance coverage are separate determinations governed by different documents and legal standards.
Coverage cannot be determined from the exclusion title alone. The operative wording, definitions, endorsements, insuring agreements, and facts alleged in the claim must be considered together. Similar exclusions may differ materially among insurers and policy forms.
GLP-1 Compounding Exclusion: Definitional FAQ
It excludes or restricts the coverage identified in the policy for claims connected to defined compounded GLP-1 medications or related professional activities.
No. The term describes a category of exclusion, while the specific wording and scope may differ among policies, endorsements, insurers, and insured operations.
Not necessarily. Depending on its wording, the exclusion may apply to insureds that prescribe, order, source, dispense, administer, distribute, recommend, or supervise the use of compounded GLP-1 medications.
Not automatically. An exclusion limited to compounded medications must be interpreted according to its definitions and operative language rather than applied solely because a claim involves a GLP-1 active ingredient.
Yes. An exclusion may contain a carve-back or conditional exception that preserves limited coverage when specifically defined requirements are satisfied.